<DOC>
	<DOCNO>NCT00004444</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare pharmacokinetics early bactericidal activity paromomycin ( aminosidine ) v streptomycin treatment uncomplicated pulmonary tuberculosis . II . Compare tolerability two drug patient . III . Establish relationship achieve serum concentration , minimal inhibitory concentration , early bactericidal activity paromomycin streptomycin .</brief_summary>
	<brief_title>Pilot Randomized Study Paromomycin ( Aminosidine ) v Streptomycin Uncomplicated Pulmonary Tuberculosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize study . Patients randomize one three treatment arm . Patients arm I II receive one two dos paromomycin intramuscularly day 3 day . Patients arm III receive streptomycin intramuscularly day 3 day . All patient begin course standard therapy tuberculosis .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>Streptomycin</mesh_term>
	<mesh_term>Paromomycin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Microbiologically proven uncomplicated pulmonary tuberculosis Positive direct sputum smear acidfast bacillus OR Presumptive diagnosis base clinical radiological finding No know risk factor multidrug resistant tuberculosis ( MDR TB ) include : Domicile , shelter , prison exposure MDR TB within 6 month Residence specific domicile , shelter , prison cell block within 6 month know outbreak MDR TB Hospitalization , within 6 month , medical service unit nosocomial transmission MDR TB know occur No clinical evidence CNS miliary tuberculosis HIV seronegative Prior/Concurrent Therapy Biologic therapy : At least 12 week since immune modulators ( include colonystimulating factor , interferon , interleukin ) Chemotherapy : No concurrent chemotherapy Endocrine therapy : At least 12 week since corticosteroid Other : At least 2 year since treatment prophylaxis tuberculosis At least 12 week since treatment drug activity tuberculosis , include : All standard drug use tuberculosis Clofazimine Rifabutin Quinolones Aminoglycosides At least 12 week since pentoxifylline Patient Characteristics Hematopoietic : Absolute neutrophil count least 1,000/mm3 Renal : Creatinine clearance great 60 mL/min Pulmonary : No chronic obstructive pulmonary disease Other : Not pregnant Fertile patient must use effective contraception No history intolerance know hypersensitivity aminoglycosides No know suspect Mycobacterium avium complex infection No serious , acute infection No diabetes No major organ dysfunction No malignancy require chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2001</verification_date>
	<keyword>bacterial infection</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>mycobacterium infection</keyword>
	<keyword>mycobacterium tuberculosis infection</keyword>
	<keyword>rare disease</keyword>
</DOC>